← All candidates
75 insider filings on record.
75 filings on record.
NPCENeuroPace Inc
NasdaqGM · Healthcare · $489.12M
$14.25
-2.33% · Sep 15
75 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$489.12M
Float
25.5M
74% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
4.6
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
70 more transactions on Pro →Context
Wall St
$20.22 avg target
+41.9% vs today · 9 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 3 quarters beat
Q4 '25−$0.08 act+$0.07
Q3 '25−$0.11 act+$0.08
Q2 '25−$0.26 act−$0.04
Coverage
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More DataMarketBeat · 07-28Here's Why You Should Retain NeuroPace Stock in Your Portfolio for NowZacks · 07-15NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant™Insider Monkey · 06-27Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to TradeZacks · 06-15
The file stays open
75 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice